Switch theme
Sign up to access all valuation multiples
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
1999
669
LTM Revenue $299M
LTM EBITDA $66.6M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Thomson Medical has a last 12-month revenue of $299M and a last 12-month EBITDA of $66.6M.
In the most recent fiscal year, Thomson Medical achieved revenue of $262M and an EBITDA of $81.7M.
Thomson Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Thomson Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $265M | $262M | XXX | XXX | XXX |
| Gross Profit | $208M | $221M | XXX | XXX | XXX |
| Gross Margin | 78% | 84% | XXX | XXX | XXX |
| EBITDA | $79.6M | $81.7M | XXX | XXX | XXX |
| EBITDA Margin | 30% | 31% | XXX | XXX | XXX |
| Net Profit | $40.1M | $27.3M | XXX | XXX | XXX |
| Net Margin | 15% | 10% | XXX | XXX | XXX |
| Net Debt | $349M | $344M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Thomson Medical's stock price is SGD 0 (or $0).
Thomson Medical has current market cap of SGD 1.1B (or $828M), and EV of SGD 2.1B (or $1.6B).
See Thomson Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $828M | XXX | XXX | XXX | XXX | $-0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Thomson Medical has market cap of $828M and EV of $1.6B.
Thomson Medical's trades at 5.2x LTM EV/Revenue multiple, and 23.3x LTM EBITDA.
Analysts estimate Thomson Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Thomson Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 5.4x | XXX | XXX | XXX |
| EV/EBITDA | 21.3x | XXX | XXX | XXX |
| P/E | 842.9x | XXX | XXX | XXX |
| P/E/Growth | 5.9x | XXX | XXX | XXX |
| EV/FCF | 41.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpThomson Medical's NTM/LTM revenue growth is 11%
Thomson Medical's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Thomson Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Thomson Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Thomson Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -1% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 36% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 65% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Thomson Medical acquired XXX companies to date.
Last acquisition by Thomson Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Thomson Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Thomson Medical founded? | Thomson Medical was founded in 1999. |
| Where is Thomson Medical headquartered? | Thomson Medical is headquartered in Singapore. |
| How many employees does Thomson Medical have? | As of today, Thomson Medical has 669 employees. |
| Is Thomson Medical publicy listed? | Yes, Thomson Medical is a public company listed on SES. |
| What is the stock symbol of Thomson Medical? | Thomson Medical trades under A50 ticker. |
| When did Thomson Medical go public? | Thomson Medical went public in 2002. |
| Who are competitors of Thomson Medical? | Similar companies to Thomson Medical include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Thomson Medical? | Thomson Medical's current market cap is $828M |
| What is the current revenue of Thomson Medical? | Thomson Medical's last 12-month revenue is $299M. |
| What is the current EBITDA of Thomson Medical? | Thomson Medical's last 12-month EBITDA is $66.6M. |
| What is the current EV/Revenue multiple of Thomson Medical? | Current revenue multiple of Thomson Medical is 5.2x. |
| What is the current EV/EBITDA multiple of Thomson Medical? | Current EBITDA multiple of Thomson Medical is 23.3x. |
| What is the current revenue growth of Thomson Medical? | Thomson Medical revenue growth between 2023 and 2024 was -1%. |
| Is Thomson Medical profitable? | Yes, Thomson Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
